Global Testosterone Replacement Therapy (TRT) Industry

NEW YORK, May 21, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Global Testosterone Replacement Therapy (TRT) Industry

http://www.reportlinker.com/p0552808/Global-Testosterone-Replacement-Therapy-TRT-Industry.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Therapy

This report analyzes the worldwide markets for Testosterone Replacement Therapy (TRT) in US$ Million. The global and the US markets are further analyzed by the following Product Segments: Gels, Patches, and Others. The report provides separate comprehensive analytics for the US, Canada, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2009 through 2017. Also, a six-year historic analysis is provided for these markets. The report profiles 19 companies including many key and niche players such as Abbott Laboratories, Acrux Limited, Auxilium Pharmaceuticals, Inc., Bayer Schering Pharma AG, Columbia Laboratories, Inc., Eli Lilly and Company, Endo Pharmaceuticals, Inc., GlaxoSmithKline plc, Kyowa Hakko Kirin Co., Ltd., ProStrakan Group PLC, Slate Pharmaceuticals, Inc., Trimel BioPharma SRL, and Watson Pharmaceuticals, Inc. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain.

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations I-1

Disclaimers I-2

Data Interpretation & Reporting Level I-3

Quantitative Techniques & Analytics I-3

Product Definitions and Scope of Study I-3

Read more from the original source:
Global Testosterone Replacement Therapy (TRT) Industry

Word Count: 229